LTR Pharma Limited (AU:LTP) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
LTR Pharma Limited is set to capture attention in the financial markets with its new fast-acting nasal spray treatment for erectile dysfunction, targeting sophisticated investors across multiple countries. The company is actively engaging with institutional accredited investors for capital raising opportunities.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.